selective adrenergic receptor adrenoreceptor antagonist beta ici binds subtype least times greater affinity two known subtypes beta compound developed imperial chemical industries acquired akzonobel known therapeutic use humans although used widely research understand action adrenergic receptor specific antagonists receptor used preclinical studies using murine dissolved saline compound crosses barrier common systemic doses used rodent research mgkg although efficacy demonstrated doses low mgkg ngkg rhesus doses mgkg used without toxicity room temperature saline ici hydrochloride soluble least mgml